Dietmar Ganßer

2.4k citations

30 papers · 1.9k indexed · 1 hit paper · h-index 19

Impact in

Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management
Cardiology and Cardiovascular Medicine top 2%
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Antiplatelet Therapy and Cardiovascular Diseases

Papers in

Internal Medicine 3
- Venous Thromboembolism Diagnosis and Management 3
Biochemistry 3

Co-authors: Joachim Stangier Hildegard Stähle Karin Rathgen Willy Roth Gerhard Spiteller Matthias Schöttner Michael Schmohl Peter Stopfer
Journals: Planta Medica (3 papers)Blood (3 papers)Journal of Agricultural and Food Chemistry (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)British Journal of Clinical Pharmacology (2 papers)
Partner nations: Germany United States Japan

In The Last Decade

Dietmar Ganßer

30 papers receiving 1.8k citations

Hit Papers

align trajectories log scale

The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects 2007 · 693 citations

Peers

Countries citing papers authored by Dietmar Ganßer

Since Specialization

Citations

This map shows the geographic impact of Dietmar Ganßer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dietmar Ganßer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dietmar Ganßer more than expected).

Fields of papers citing papers by Dietmar Ganßer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dietmar Ganßer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dietmar Ganßer. The network helps show where Dietmar Ganßer may publish in the future.

Co-authors

The 25 scholars most cited alongside Dietmar Ganßer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Dietmar Ganßer Line = papers co-authored together Dietmar Ganßer links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Pharmacokinetics of idarucizumab and its target dabigatran in patients requiring urgent reversal of the anticoagulant effect of dabigatran Journal of Thrombosis and Haemostasis ·Stephan Glund, Y. Buianover, Dietmar Ganßer, Joachim Stangier, Vladimir Polansky, Charles V. Pollack, Paul Reilly	2019	5
2	Optimization of a drug transporter probe cocktail: potential screening tool for transporter‐mediated drug–drug interactions British Journal of Clinical Pharmacology ·Peter Stopfer, Thomas Gießmann, Kathrin Hohl, Zainab Aun Ali Alzainy, Sven Schmidt, Dietmar Ganßer, Naoki Ishiguro, Mitchell E. Taub, Vishal U. Patil, Thomas Ebner, Fabian Müller	2018	40
3	Safety, pharmacokinetics and pharmacodynamics of idarucizumab, a specific dabigatran reversal agent in healthy Japanese volunteers: a randomized study Research and Practice in Thrombosis and Haemostasis ·Masahiro Yasaka, Ippei Ikushima, Akiko Harada, JI Perales Martinez, Atsushi Taniguchi, Stephen H. Norris, Dietmar Ganßer, Joachim Stangier, Michael Schmohl, Paul Reilly	2017	13
4	Effects of Metformin and Furosemide on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Implications for Their Use as Probe Drugs in a Transporter Cocktail European Journal of Drug Metabolism and Pharmacokinetics ·Peter Stopfer, Thomas Gießmann, Kathrin Hohl, Vishal U. Patil, Naoki Ishiguro, Mitchell E. Taub, Arvid Jungnik, Dietmar Ganßer, Thomas Ebner, Fabian Müller	2017	27
5	Effect of Age and Renal Function on Idarucizumab Pharmacokinetics and Idarucizumab-Mediated Reversal of Dabigatran Anticoagulant Activity in a Randomized, Double-Blind, Crossover Phase Ib Study Clinical Pharmacokinetics ·Stephan Glund, Joachim Stangier, Joanne van Ryn, Michael Schmohl, Viktoria Moschetti, Wouter Haazen, Marina De Smet, Dietmar Ganßer, Stephen H. Norris, Benjamin Lang, Paul Reilly, Jörg Kreuzer	2016	58
6	Influence of Renal Impairment on the Pharmacokinetics of Afatinib: An Open-Label, Single-Dose Study European Journal of Drug Metabolism and Pharmacokinetics ·Sabrina Wiebe, David Schnell, Crea Carberry, Dietmar Ganßer, Anne Weber, G. Wallenstein, Atef Halabi, Wanyi Liu, Sven Wind	2016	17
7	Measurement of dabigatran plasma concentrations by calibrated thrombin clotting time in comparison to LC-MS/MS in human volunteers on dialysis Thrombosis Research ·Michael Schmohl, Dietmar Ganßer, Viktoria Moschetti, Joachim Stangier	2015	11
8	Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial The Lancet ·Stephan Glund, Joachim Stangier, Michael Schmohl, Dietmar Ganßer, Stephen H. Norris, Joanne van Ryn, Benjamin Lang, Steven Ramael, Viktoria Moschetti, Fredrik Gruenenfelder, Paul Reilly, Jörg Kreuzer	2015	237
9	Pharmacokinetics of afatinib in subjects with mild or moderate hepatic impairment Cancer Chemotherapy and Pharmacology ·David Schnell, К.Ю. Клещевникова, Holger Fuchs, Dietmar Ganßer, Rainer-Georg Goeldner, Martina Uttenreuther‐Fischer, Peter Stopfer, Sven Wind, P. Hobson, Atef Halabi, Ata Ullah	2014	32
10	Idarucizumab, a Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Elderly and Renally Impaired Subjects Blood ·Stephan Glund, Joachim Stangier, Michael Schmohl, Viktoria Moschetti, Wouter Haazen, Marina De Smet, Dietmar Ganßer, Stephen H. Norris, Benjamin Lang, Paul Reilly	2014	59
11	Brain Penetration of WEB 2086 (Apafant) and Dantrolene in Mdr1a (P-Glycoprotein) and Bcrp Knockout Rats Drug Metabolism and Disposition ·Holger Fuchs, Wataru Kishimoto, Dietmar Ganßer, P. Tanswell, Naoki Ishiguro	2014	17
12	Pharmacokinetic Drug Interactions of Afatinib with Rifampicin and Ritonavir Clinical Drug Investigation ·Sven Wind, Thomas Gießmann, Arvid Jungnik, Íris Mist Magnúsdóttir, Kristell Marzin, T. Akkuş, Jose M Lamberty, Dietmar Ganßer, Peter Stopfer	2014	54
13	Abstract 17765: A Specific Antidote for Dabigatran: Immediate, Complete and Sustained Reversal of Dabigatran Induced Anticoagulation in Healthy Male Volunteers Circulation ·Stephan Glund, Joachim Stangier, Michael Schmohl, Marina De Smet, Dietmar Ganßer, Benjamin Lang, Viktoria Moschetti, Steven Ramael, Paul Reilly	2013	41
14	Afatinib pharmacokinetics and metabolism after oral administration to healthy male volunteers Cancer Chemotherapy and Pharmacology ·Peter Stopfer, Kristell Marzin, H. Narjes, Dietmar Ganßer, Mehdi Shahidi, S. Lindenbaum, Thomas Ebner	2011	113
15	Pharmacokinetics (PK) of [¹⁴C]-BIBW 2992 after administration of a single dose of 15 mg [¹⁴C]-BIBW 2992 oral solution in healthy male volunteers Journal of Clinical Oncology ·Peter Stopfer, H. Narjes, Birgit Gaschler‐Markefski, Dietmar Ganßer, Maryam Shahidi	2008	2
16	The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjects British Journal of Clinical Pharmacology ·Joachim Stangier, Karin Rathgen, Hildegard Stähle, Dietmar Ganßer, Willy Roth Hit paper breakdown →	2007	693
17	Lignans from the Roots ofUrtica dioicaand their Metabolites Bind to Human Sex Hormone Binding Globulin (SHBG) Planta Medica ·Matthias Schöttner, Dietmar Ganßer, Gerhard Spiteller	1997	77
18	Analysis of oxylipins by high‐performance liquid chromatography with evaporative light‐scattering detection and particle beam‐mass spectrometry Lipids ·Jason C. Livingston, Dietmar Ganßer, Ralf G. Berger	1997	10
19	Aromatase Inhibitors fromUrtica dioicaRoots Planta Medica ·Dietmar Ganßer, Gerhard Spiteller	1995	42
20	Biotransformation of the Naturally Occurring Lignan (-)-Arctigenin in Mammalian Cell Lines Genetically Engineered for Expression of Single Cytochrome P450 Isoforms Planta Medica ·Rachel Kasper, Dietmar Ganßer, Johannes Doehmer	1994	8

About Dietmar Ganßer

Dietmar Ganßer is a scholar working on Internal Medicine, Biochemistry, Complementary and alternative medicine, Cardiology and Cardiovascular Medicine and Pharmacology, having authored 30 papers that have together received 1.9k indexed citations. Recurring topics across this work include Atrial Fibrillation Management and Outcomes (9 papers), Drug Transport and Resistance Mechanisms (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Lung Cancer Treatments and Mutations (4 papers), Medicinal plant effects and applications (3 papers), Cardiac Arrhythmias and Treatments (3 papers), Acute Myocardial Infarction Research (3 papers) and Venous Thromboembolism Diagnosis and Management (3 papers). The work is most often cited by research in Internal Medicine (727 citations), Cardiology and Cardiovascular Medicine (1.0k citations), Pharmacology (147 citations), Biochemistry (90 citations) and Hematology (167 citations). Dietmar Ganßer has collaborated with scholars based in Germany, United States and Japan. Frequent co-authors include Joachim Stangier, Hildegard Stähle, Karin Rathgen, Willy Roth, Gerhard Spiteller, Matthias Schöttner, Michael Schmohl, Peter Stopfer, Viktoria Moschetti and Paul Reilly. Their work appears in journals such as Planta Medica, Blood, Journal of Agricultural and Food Chemistry, Cancer Chemotherapy and Pharmacology and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact